Post-SSRI sexual dysfunction (PSSD)
Post-SSRI sexual dysfunction, or PSSD, means sexual changes that carry on or begin after a serotonin reuptake inhibitor antidepressant is stopped. Often the main feature is genital numbness, along with lower desire and weak or pleasureless orgasm. The US label for Prozac says sexual symptoms occasionally persist after the medication is stopped. Its cause is not understood and there is no proven treatment yet, so if sexual changes continue after stopping, tell your doctor.
Also called: PSSD, Sexual dysfunction after stopping an SSRI.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
What are the symptoms of PSSD?
The changes people describe most are genital numbness or reduced genital sensation, weak or pleasureless orgasm, loss of desire and impotence. Those come from the 300 reports gathered by Healy and colleagues in 2018. Genital numbness can carry over from the time on the medication or show up for the first time after the last dose.
The same kinds of change are listed for the time you are taking the medication. The US label for Lexapro says SSRIs may cause sexual dysfunction: in males, delayed or failed ejaculation, lower desire and erectile problems, and in females, lower desire and delayed or absent orgasm. What marks PSSD out is that the changes carry on after the last dose instead of easing.
Will PSSD go away?
Nobody can yet say how often it clears, or how long it takes. What exists is mostly reports people sent in themselves. The 2018 paper by Healy, Le Noury and Mangin pulled together 300 of them from 37 countries, sent to RxISK.org, a website that collects reports of side effects. They covered 14 drugs: serotonin reuptake inhibiting antidepressants, finasteride-type drugs and isotretinoin. Reports like these show that the problem is real and what it looks like. They cannot show how common it is or how it ends, because there is no count of everyone who stopped an antidepressant and had no trouble.
Could something else explain the symptoms?
It is worth checking, and the Lexapro label asks prescribers to do exactly that. It says sexual symptoms may have other causes, including the psychiatric condition being treated, and that a detailed history matters, with the timing of when symptoms began. Depression and anxiety both lower desire, so the dates are what make the picture readable: when the medication started, when it stopped, and when each change began.
One sign points away from the illness itself. Genital numbness is not a symptom of depression, and a 2026 review names it as what separates PSSD from depression coming back.
What if you are still taking the antidepressant?
Sexual changes that start while you are on an SSRI are common, and they are worth raising before you change anything about the medication. Tell your prescriber which changes you have and when each one began, and ask whether anything in your treatment should change.
What to do
If sexual changes continue after you stop an antidepressant, tell your prescriber. Note when the medication stopped, which changes you have, and whether any were there before you started, so they can check for other causes and plan next steps.
Check whether a symptom is common
How withClaro helps
- Log changes privately, next to the dose you took
- Share a dated report before your appointment
Get the withClaro app on the App Store
Related terms
Sources
- U.S. Food and Drug Administration. Prozac (fluoxetine): prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- Healy D, Le Noury J, Mangin D. Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases. International Journal of Risk & Safety in Medicine, 2018.
- Xie M, Huang P, Wang S, Ma J, Zeng Y, Sun J. Post-SSRI sexual dysfunction (PSSD): a comprehensive review of epidemiology, pathophysiology, and clinical management. International Journal of Risk & Safety in Medicine, 2026.
All glossary terms